Table 4

Population-average of the EERO among women and men aged 77 years with no ocular comorbidities and population-average difference in EERO between patients with posterior capsular rupture plus another specified ocular comorbidity compared with patients without posterior capsular rupture nor the other specified ocular comorbidity, all else being equal

Posterior mean/mean difference95% credible interval
Population-average of EERO in reference patients
Women aged 77 years with no ocular comorbidities*−0.30/0.45×4−0.32/0.46×5 to –0.29/0.45×4
Men aged 77 years with no ocular comorbidities*−0.13/0.40×5−0.14/0.40×5 to −0.12/0.40×4
Population-average difference in EERO
Posterior capsular rupture and brunescent/white mature cataract−0.38/0.05×71−0.42/0.07×64 to −0.34/0.04×83
Posterior capsular rupture and pseudoexfoliation/phacodonesis−0.30/0.02×75−0.36/0.05×59 to −0.26/0.02×110
Posterior capsular rupture and high myopia−0.45/0.06×66−0.49/0.08×61 to −0.41/0.05×74
Posterior capsular rupture and uveitis/synaechiae−0.40/0.04×46−0.46/0.07×46 to −0.34/0.01×46
  • Results reported as compound numbers: sphere/cylinder×axis.

  • *With a subjective refraction observed within 3 months of operation.

  • EERO, error of expected refractive outcome.